
BZAM Ltd. & 4C Labs Conclude Strategic Distribution Agreement for the UK Market
BZAM Ltd. (the “Company” or “BZAM”) (CSE: BZAM) (US-OTC:BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman
BZAM Ltd. (the “Company” or “BZAM”) (CSE: BZAM) (US-OTC:BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman
Canadian cannabis producer Organigram is set to bring its products to the UK’s medical cannabis market for the first time
4C LABS Ltd. (the “Company” or “4C LABS Ltd”) is pleased to announce that it has entered into a strategic
4C LABS has announced a new tie-up with Canadian cannabis producer BZAM, which will see it import 1,200 kg of
4C LABS Ltd., a London based Phyto Pharma company focused on the medical cannabis space, has been granted Importation and
4C LABS has officially received a specialist clinic licence from the UK’s Care Quality Commission (CQC), enabling it to launch
4C LABS has become the first and only company to be awarded a medical cannabis cultivation licence in Guernsey marking
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.